<DOC>
	<DOCNO>NCT00910689</DOCNO>
	<brief_summary>The purpose study determine addition preventive medication , behavior migraine management combination preventive medication behavior migraine management improve outcome optimal acute therapy frequent migraine .</brief_summary>
	<brief_title>Drug Non-Drug Treatment Of Severe Migraine</brief_title>
	<detailed_description>During 5 week Optimal Acute Therapy ( OAT ) Run ( Month 1 ) participant meet initial inclusion criterion receive `` optimal '' acute therapy ( OAT ) . At end OAT Run-in , participant continue meet migraine severity criterion stratify sex randomize via computerized randomization procedure four add treatment : Beta Blocker Placebo ( PL ) , Beta Blocker ( Propranolol LA Nadolol ) , Behavioral Migraine Management ( BMM ) + PL , BMM + Beta Blocker . Each 4 treatment protocol require 4 monthly clinic visit 3 telephone contact 3 month Treatment/Dose Adjustment Phase ( Month 2 Month 4 ) Beta Blocker PL dose adjust BMM administer . During 12 month ( Month 5 Month 16 ) Evaluation Phase clinic visit schedule Month 5 , Month 7 , Month 10 ( Primary End Point ) , Month 13 Month 16 . Treatment condition blind preventive medication ( Beta Blocker , Placebo ) component , administration BMM . Electronic headache diary recording obtain full 16 month trial , include 12 month evaluation phase , migraine-related impairment quality life assess multiple point 16 month trial .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<mesh_term>Nadolol</mesh_term>
	<criteria>18 65 year Diagnosis migraine without aura ( International Classification Headache Disorders ) 3 migraine episodes/month disability past 6 month Less 20 total headache days/month past 6 month Medication overuse headache Currently take medication contraindicate study protocol unable unwilling withdraw Concurrently undergo counseling/psychotherapy treatment Unable read , understand record information study diary , questionnaire , migraine management manual . Unable/unwilling give write informed consent History exclusionary medical condition , limited , epilepsy , heart disease , kidney disease , liver disease , hepatic renal impairment , stroke , ischemic abdominal syndrome , peripheral vascular disease . Uncontrolled hypertension screening ( sit systolic pressure &gt; 160 mmHg , diastolic pressure &gt; 95 mmHg ) Fertile female breastfeeding , pregnant planning pregnancy within next year unwilling use adequate contraception . Has exclusionary medical condition limit diabetes ( insulin dependent ) , tuberculosis , bronchospastic disease ( asthma ) , heart disease ( multiple risk factor heart disease ) , angina pectoris , document silent ischemia , cardiac arrythmias require medication , clinically significant EKG abnormality . Other pain diagnosis primary presenting problem ( e.g. , fibromyalgia ) Has substance abuse problem psychological disorder prevents participation study ( e.g. , unmanaged severe depression require immediate treatment limit participation homebased treatment ) Hypersensitivity , intolerance contraindication use Propranolol , Nadolol , Sumatriptan , Rizatriptan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Migraine Headache</keyword>
	<keyword>Preventive Therapy</keyword>
	<keyword>Beta Blocker Medication</keyword>
	<keyword>Behavior Therapy</keyword>
	<keyword>Clinical Trial</keyword>
</DOC>